Evidence map›Paper›PMID 35790594›Full record

ArticleClinical rheumatology2022

Perception of risk and impact of the COVID-19 pandemic on patients with rheumatic diseases: a case-control study.

Alfonso Gastelum-Strozzi, Virginia Pascual, Adolfo Hernández-Garduño, José Francisco Moctezuma-Rios, Guillermo Arturo Guaracha-Basañez, Thalya Sotelo, Conrado Garcia-Garcia, Irazú Contreras-Yañez, Everardo Álvarez-Hernández, Claudia Infante-Castañeda and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Alfonso Gastelum-StrozziICAT Universidad Nacional Autonoma de Mexico (UNAM), Mexico City, Mexico.ORCID http://orcid.org/0000-0001-9668-5822
Virginia PascualRheumatology Department, Instituto Nacional de Ciencias Medicas Y Nutrición Salvador Zubirán (INCMNSZ), Mexico City, Mexico.ORCID http://orcid.org/0000-0002-7368-498X
Adolfo Hernández-GarduñoAHS Health Consulting, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-6482-0265
José Francisco Moctezuma-RiosRheumatology Unit, Hospital General de México "Dr. Eduardo Liceaga", Dr. Balmis 148, Col Doctores, C.P. 06726, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-5339-9620
Guillermo Arturo Guaracha-BasañezInstituto Nacional de Ciencias Medicas Y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-8060-7301
Thalya SoteloRheumatology Unit, Hospital General de México "Dr. Eduardo Liceaga", Dr. Balmis 148, Col Doctores, C.P. 06726, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-8999-8131
Conrado Garcia-GarciaRheumatology Unit, Hospital General de México "Dr. Eduardo Liceaga", Dr. Balmis 148, Col Doctores, C.P. 06726, Mexico City, Mexico.ORCID http://orcid.org/0000-0003-1477-5651
Irazú Contreras-YañezRheumatology Department, Instituto Nacional de Ciencias Medicas Y Nutrición Salvador Zubirán (INCMNSZ), Mexico City, Mexico.ORCID http://orcid.org/0000-0001-6711-2275
Everardo Álvarez-HernándezRheumatology Unit, Hospital General de México "Dr. Eduardo Liceaga", Dr. Balmis 148, Col Doctores, C.P. 06726, Mexico City, Mexico.ORCID http://orcid.org/0000-0003-2557-5866
Claudia Infante-CastañedaInstituto de Investigaciones Sociales, UNAM, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-2798-8448
Ingris Peláez-BallestasRheumatology Unit, Hospital General de México "Dr. Eduardo Liceaga", Dr. Balmis 148, Col Doctores, C.P. 06726, Mexico City, Mexico. pelaezin@gmail.com.ORCID http://orcid.org/0000-0001-5188-7375
Hospital General de México · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXInstituto de Investigaciones SocialesUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesRisk perception of the COVID-19 pandemic may affect chronic disease outcomes among patients with rheumatic diseases (RD). To describe and compare the perception of risk and effects of the COVID-19 pandemic on patients with RD from two health care centers compared with a control group.

methodsA retrospective case-control study was conducted. Patient respondents completed an online survey to measure risk perception and effects of the COVID-19 pandemic. The case group consisted of patients with a confirmed diagnosis of RD, coming from two third-level health care centers. The control group was a population group without RD from a public university.

resultsA total of 3944 participants were included: 986 patients with an RD (cases) from the two hospital centers and 2958 controls without RD. A greater perception of risk severity and perception of contagion was observed in the group of patients with RD, OR: 1.70, 95% CI 1.44‒2.01 and OR: 2.0, 95% CI 1.79‒2.23, respectively; more significant deterioration in family life OR: 1.14, 95% CI 1.01‒1.29; greater economic impact, OR 3.94, 95% CI 3.48‒4.46; as well as negative emotions and feelings (alarmed, anxiety, depression, confusion, fear, isolation, and discrimination). This impact was maintained when the model was adjusted for comorbidities.

conclusionIn the face of an unexpected and catastrophic event such as the COVID-19 pandemic, patients with RD report apparently greater impact on their mental state and economic situation than the control population, as well as increased perception of discrimination. Key Points • The multidisciplinary analyses of risk perception are required to promote actions that can enhance the preparedness and responses of public efforts for possible future pandemics in a way that considers the specific needs of vulnerable people like patients with rheumatic diseases. • Identifying risk perceptions of possible effects of the pandemic, sources of communication, and opinions is essential to ensure self-care in rheumatic disease. • The impact of COVID-19 has been much greater for people with rheumatic disease, especially in terms of the perceived severity of the pandemic, impacts on family and economy, preventive behaviors, and uncertainty.

Indexed as

COVID-19Rheumatic DiseasesCase-Control StudiesHumansPandemicsPerceptionRetrospective StudiesSARS-CoV-2Case–control studyCOVID-19ImpactRheumatic DiseaseRisk perception

Identifiers

PMID35790594
PMCPMC9255952
OpenAlexW4284683356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.